Home | Markers | Who to Treat

Who to Treat

For prostate cancer has been a huge challenge. These tests help us determine who is at low risk for their disease to ever cause a problem and who will benefit from treatment.

ProMark

ProMark is an advanced prognostic test developed specifically for prostate cancer. If you have a biopsy Gleason score 3+3 or 3+4, ProMark uses automated image recognition technology to predict risk of having an aggressive prostate cancer.

Downloads

ProMark Information

AR-V7

Finding the most effective treatment for your patients with metastatic castration-resistant prostate cancer (mCRPC) can be a challenge. The Oncotype DX AR-V7 Nucleus Detect test helps you quickly and confidently determine the next step.

oncotypeDx AR-V7 logo

Downloads

AR-V7 Information

Prolaris

Prolaris is a measure of how fast a prostate cancer tumor is growing. Biopsy tissue samples can be used to determine a patient’s personal Prolaris Score. Studies have shown that Prolaris provides an accurate assessment of cancer aggressiveness.

Downloads

Prolaris Information

Oncotype Dx

The Oncotype DX Gemonic Prostate Score harnesses the power of genomics to provide a more precise and accurate assessment of risk based on individual tumor biology.

Oncotype DX GPS Lockup CMYK M01

Downloads

Oncotype DX Patient Brochure

Decipher Prostate Biopsy

Decipher Prostate Biopsy is a genomic test performed on tumor tissue that helps match selection and intensity of treatment with the metastatic potential of the tumor.